Autophagy-focused Casma Therapeutics debuts with $58.5 million from Third Rock
Wednesday, July 25, 2018 - 14:58
in Health & Medicine
The biotech will first tackle lysosomal storage disorders
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via